CH
Insider
Christopher Hite
EVP & Chairman, PartneringChristopher Hite (EVP & Chairman, Partnering) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Royalty Pharma plc (RPRX). The largest single filing was $8.2M of RPRX (150,000 sh across 2 lots, as filed), executed Jun 23.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$21.5M
shares × price, as filed
Last traded
Aug 18
Filed Aug 19
Median ADV $206.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $21.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
RPRXRecent filings
RPRXSALE
Royalty Pharma plc
View filing →
$6.0M100,000 sh × $59.97
Exec Aug 18
Filed Aug 19 · 4:20 PM ET RPRXSALE Royalty Pharma plc View filing → $7.3M
129,400 sh across 3 lots
Exec Jun 30
Filed Jul 2 · 4:08 PM ET RPRXSALE Royalty Pharma plc View filing → $8.2M
150,000 sh across 2 lots
Exec Jun 23
Filed Jun 25 · 5:30 PM ET